NASDAQ Biotechnology Total Retu XNBI Indice
4612.3 USD
{{ price }}
1.755793%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
4567.55
-
4619.26 USD
Numero di componenti
190
NASDAQ Biotechnology Total Retu Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
| MGNX | MacroGenics | +26.9% | |
|---|---|---|---|
| PACB | Pacific Biosciences of California | +13.5% | |
| OMER | Omeros | +13.18% | |
| MCRB | Seres Therapeutics | +12.08% | |
| CERS | Cerus Corporation | +11.96% |
Top 5 Perdenti delle Ultime 24 Ore
| CRIS | Curis | -3.35% | |
|---|---|---|---|
| TRVN | Trevena | -3.04% | |
| PCRX | Pacira BioSciences | -2.36% | |
| ARRY | Array | -1.96% | |
| ALNY | Alnylam Pharmaceuticals | -1.89% |
NASDAQ Biotechnology Total Retu XNBI PANORAMICA FINANZIARIA E DI TRADING
| NASDAQ Biotechnology Total Retu Prezzo dell'Indice | 4612.3 USD |
| Chiusura Precedente | 4472.96 USD |
| Apertura | 4476.26 USD |
| Prezzo di Acquisto | 0 USD x 0 |
| Prezzo di Vendita | 0 USD x 0 |
| Variazione Giornaliera | 4464.53 - 4532.84 USD |
| Variazione a 52 Settimane | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume Medio | N/A |
Informazioni di trading
NASDAQ Biotechnology Total Retu Storico dei prezzi dell'Indice
| Massimo a 52 Settimane | 4532.84 USD |
| Minimo a 52 Settimane | 4464.53 USD |
| Media Mobile a 50 Giorni | N/A |
| Media Mobile a 200 Giorni | N/A |
XNBI Statistiche dell'indice
| Volume Medio (3 Mesi) | N/A |
| Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice NASDAQ Biotechnology Total Retu
Qual è il prezzo attuale dell'Indice XNBI?
Il prezzo dell'Indice NASDAQ Biotechnology Total Retu XNBI oggi è di 4612.3 USD.
Come acquistare l'Indice NASDAQ Biotechnology Total Retu?
Puoi acquistare l'indice XNBI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice NASDAQ Biotechnology Total Retu?
La sigla (o ticker) dell'Indice NASDAQ Biotechnology Total Retu è XNBI.
Quanti componenti contiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu contiene 190 componenti.
A quale paese appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento a United States.
A quale borsa appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento alla borsa Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPONENTI
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $290.79 — |
+1.29
|
$156.36B — | $1.09M — | $289.5 — | $293.57 — | $156.36B — | 26.50 | $10.97 — |
| Gilead Sciences GILD | $112.21 — |
+1.58
|
$139.58B — | $2.33M — | $110.77 — | $112.34 — | $139.58B — | 23.57 | $4.76 — |
| Vertex Pharmaceuticals Incorporated VRTX | $448.62 — |
+1.08
|
$115.2B — | $440.58K — | $443.83 — | $451.63 — | $115.2B — | 0 | -$3.82 — |
| Regeneron Pharmaceuticals REGN | $495.29 — |
+2.53
|
$53.47B — | $684.14K — | $485 — | $499.84 — | $53.47B — | 12.59 | $39.32 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $302.19 — |
-1.89
|
$39.4B — | $470.91K — | $300.27 — | $310 — | $39.4B — | 0 | -$2.09 — |
| Biogen BIIB | $132.89 — |
+1.94
|
$19.47B — | $528.65K — | $131.5 — | $133.69 — | $19.47B — | 13.13 | $10.12 — |
| United Therapeutics UTHR | $324.53 — |
+1.51
|
$14.64B — | $151.86K — | $322.76 — | $325.98 — | $14.64B — | 12.92 | $25.11 — |
| Insmed Incorporated INSM | $73.63 — |
+1.22
|
$13.41B — | $756.98K — | $72.8 — | $74.07 — | $13.41B — | 0 | -$5.93 — |
| Incyte INCY | $68.83 — |
+2.36
|
$13.32B — | $799.39K — | $67.62 — | $68.98 — | $13.32B — | 344.14 | $0.2 — |
| Illumina ILMN | $82.94 — |
+0.83
|
$13.13B — | $824.25K — | $82.73 — | $84.56 — | $13.13B — | 0 | -$6.08 — |
| Neurocrine Biosciences NBIX | $124.17 — |
-0.35
|
$12.29B — | $458.54K — | $124.13 — | $126.81 — | $12.29B — | 42.09 | $2.95 — |
| Exelixis EXEL | $42.56 — |
+0.45
|
$11.61B — | $976.54K — | $42.48 — | $43.06 — | $11.61B — | 19.43 | $2.19 — |
| BioMarin Pharmaceutical BMRN | $56.6 — |
+2.41
|
$10.85B — | $1.22M — | $55.64 — | $57.76 — | $10.85B — | 20.96 | $2.7 — |
| Qiagen QGEN | $45.35 — |
-0.48
|
$9.82B — | $474.17K — | $45.29 — | $45.88 — | $9.82B — | 105.46 | $0.43 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Blueprint Medicines BPMC | $127.95 — |
+0.04
|
$8.27B — | $2.19M — | $127.91 — | $128.07 — | $8.27B — | 0 | -$2.51 — |
| Bio-Techne TECH | $48.87 — |
+1.16
|
$7.66B — | $509.36K — | $48.63 — | $49.49 — | $7.66B — | 58.87 | $0.83 — |
| Grifols, S.A. GRFS | $8.88 — |
+1.83
|
$7.34B — | $336.77K — | $8.73 — | $8.92 — | $7.34B — | 34.15 | $0.26 — |
| Repligen RGEN | $128.86 — |
+1.7
|
$7.24B — | $320.23K — | $127.8 — | $130.6 — | $7.24B — | 0 | -$0.42 — |
- {{ link.label }} {{link}}